News . Data . Research
Alexion Pharmaceuticals (NASDAQ: ALXN) announced today that it will be acquiring commercial-stage biopharmaceutical company Portola Pharmaceuticals (NASDAQ: PTLA) for an initial consideration
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported a 36% jump in earnings for the first quarter of 2020 helped by higher revenue. The
Varian Medical Systems Inc (VAR) Q2 2020 earnings call dated May 04, 2020 Corporate Participants: Anshul Maheshwari -- Vice President, Treasury and Investor Relations
AbbVie (NYSE: ABBV), which is expecting to close the acquisition of Allergan in this month, reported its first quarter 2020 earnings results
COVID-19 has been pretty disruptive on clinical-level biotech and pharmaceutical companies worldwide, especially those running on tight budgets. Clinical trials have been
PetMed Express Inc (PETS) Q4 2019 earnings call dated May. 04, 2020 Corporate Participants: Bruce S. Rosenbloom -- Chief Financial Officer and Treasurer Menderes
Novartis International AG (NVS) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vasant Narasimhan -- Chief
Trxade Group Inc. (NASDAQ: MEDS) reported its financial results for the quarter ended March 31, 2020, on Monday, May 4, before the
Viking Therapeutics Inc (VKTX) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Stephanie Diaz -- Manager, Investor Relations Brian Lian -- President and Chief
Baxter International Inc (BAX) Q1 2020 earnings call dated April 30, 2020 Corporate Participants: Clare Trachtman -- Vice President, Investor Relations Jose E. Almeida -- Chairman,
AbbVie Inc (ABBV) Q1 2020 earnings call dated May. 01, 2020 Corporate Participants: Liz Shea -- Vice President, Investor Relations Richard A. Gonzalez -- Chairman of
ImmunoGen Inc. (IMGN) Q1 2020 earnings call dated May 01, 2020 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor Relations
Cigna Corp. (CI) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: William McDowell -- Vice President of Investor Relations David M. Cordani -- President,
AbbVie (NYSE: ABBV) reported its first quarter 2020 earnings results, which surpassed the market's views. Adjusted EPS of $2.42 and revenue of
Amgen Inc (AMGN) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Arvind Sood -- Vice President of Investor Relations Robert A. Bradway -- Chairman
Amarin Corporation plc (AMRN) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director of Investor Relations John F.
Illumina Inc (ILMN) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Jacquie Ross -- Vice President of Corporate Communications and Corporate Social
Gilead Sciences Inc. (GILD) Q1 2020 earnings call dated April 30, 2020 Corporate Participants: Douglas Maffei -- Investor Relations Daniel O'Day -- Chairman and Chief Executive
Amgen's (NASDAQ: AMGN) top and bottom line in the first quarter of 2020 beat analysts' estimates. The biotech firm's adjusted earnings per
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Thursday said its first-quarter earnings increased, aided by higher revenues. The results also exceeded the
Abiomed Inc (ABMD) Q4 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Todd A.Trapp -- Vice President and Chief Financial Officer Michael R.